TRIMU 5
From Wikipedia, the free encyclopedia
![]() |
This article needs more links to other articles to help integrate it into the encyclopedia. (January 2017) (Learn how and when to remove this template message) |
![]() |
|
Names | |
---|---|
IUPAC name
L-tyrosyl-N-{[(3-methylbutyl)amino]acetyl}-D-alaninamide
|
|
Other names
(2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1-{[2-(3-methylbutylamino)acetyl]amino}-1-oxopropan-2-yl]propanamide
|
|
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
|
|
|
|
Properties | |
C19H30N4O4 | |
Molar mass | 378.466 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
TRIMU 5 is a selective agonist of the mu opioid receptor type 2.[1]
References[edit]
- ^ Eisenberg RM (1994). "TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis". Pharmacol. Biochem. Behav. 47 (4): 943–6. PMID 8029266. doi:10.1016/0091-3057(94)90300-X.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |